These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16326434)

  • 1. In vitro investigation of the hepatic intrinsic clearance of apicidin, a histone deacetylase inhibitor, in mouse, rat, and human, with correction by nonspecific protein binding.
    Shin BS; Park EH; Yoon CH; Kim J; Zee O; Yoo SD
    J Toxicol Environ Health A; 2005 Dec; 68(23-24):2207-18. PubMed ID: 16326434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling.
    Shin BS; Bulitta JB; Balthasar JP; Kim M; Choi Y; Yoo SD
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):465-75. PubMed ID: 21069337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats.
    Shin BS; Chang HS; Park EH; Yoon CH; Kim HY; Kim J; Ryu JK; Zee OP; Lee KC; Cao D; Yoo SD
    Biopharm Drug Dispos; 2006 Mar; 27(2):69-75. PubMed ID: 16299816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
    Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
    Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
    Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenacetin deacetylase activity in human liver microsomes: distribution, kinetics, and chemical inhibition and stimulation.
    Kudo S; Umehara K; Hosokawa M; Miyamoto G; Chiba K; Satoh T
    J Pharmacol Exp Ther; 2000 Jul; 294(1):80-8. PubMed ID: 10871298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.
    Ashforth EI; Carlile DJ; Chenery R; Houston JB
    J Pharmacol Exp Ther; 1995 Aug; 274(2):761-6. PubMed ID: 7636740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data.
    Hayes KA; Brennan B; Chenery R; Houston JB
    Drug Metab Dispos; 1995 Mar; 23(3):349-53. PubMed ID: 7628300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.
    Obach RS
    Drug Metab Dispos; 1999 Nov; 27(11):1350-9. PubMed ID: 10534321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood.
    Xiao JJ; Byrd J; Marcucci G; Grever M; Chan KK
    Rapid Commun Mass Spectrom; 2003; 17(8):757-66. PubMed ID: 12672127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative mutagenicity of apicidin and apicidin derivatives (SD-0203 and SD-2007), histone deacetylase inhibitors.
    Yoo EJ; Lee BM
    J Toxicol Environ Health A; 2005 Dec; 68(23-24):2097-109. PubMed ID: 16326426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites.
    Kim S; Kang JK; Kim YK; Seo DW; Ahn SH; Lee JC; Lee CH; You JS; Cho EJ; Lee HW; Han JW
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1168-73. PubMed ID: 16516150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
    You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
    Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir.
    Parker AJ; Houston JB
    Drug Metab Dispos; 2008 Jul; 36(7):1375-84. PubMed ID: 18426953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes.
    Abass K; Reponen P; Turpeinen M; Jalonen J; Pelkonen O
    Drug Metab Dispos; 2007 Sep; 35(9):1634-41. PubMed ID: 17576805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T; Takai N; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New method for the simultaneous estimation of intrinsic hepatic clearance and protein binding by matrix inhibition.
    Uchimura T; Kato M; Tachibana T; Arai S; Nabuchi Y; Saito K; Kinoshita H
    Biopharm Drug Dispos; 2008 Jan; 29(1):7-16. PubMed ID: 17941035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.